Wells Fargo analyst Christopher Harris believes the VIX complex volumes bottomed in August, creating and attractive risk/reward for shares of Cboe Global Markets (CBOE) heading into the fall. Supporting data include steadily rising open interest trends, recent improvement in volume trends and better VIX exchange-traded product flows, Harris tells investors in a research note. In addition, Cboe's relative valuation versus CME Group (CME) "has rarely been this low," the analyst adds. He keeps an Outperform rating on Cboe Global Markets with a $115 price target.

Reports Q1 revenue $1.49B, consensus $1.48B. "CME Group adjusted net income and earnings per share reached new records in Q1 as investors turned to our markets to manage through the ongoing economic and geopolitical uncertainty in today's marketplace," said Terry Duffy, CME Group Chairman and CEO. "Average daily volume in our U.S. Treasury futures and options grew 12% year over year, reaching a new all-time high of 7.8 million contracts per day. Additionally, ADV in our commodities markets increased 14% to 4.7 million contracts. Looking ahead, we remain committed to providing the deep liquidity and unparalleled capital efficiencies our clients rely on as they continue to navigate a wide range of risks across asset classes."